Validity of Quantitative Lymphoscintigraphy as a Lymphedema Assessment Tool for Patients With Breast Cancer
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objective To evaluate the validity of quantitative lymphoscintigraphy as a useful lymphedema assessment tool for patients with breast cancer surgery including axillary lymph node dissection (ALND). Methods We recruited 72 patients with lymphedema after breast cancer surgery that included ALND. Circumferences in their upper limbs were measured in five areas: 15 cm proximal to the lateral epicondyle (LE), the elbow, 10 cm distal to the LE, the wrist, and the metacarpophalangeal joint. Then, maximal circumference difference (MCD) was calculated by subtracting the unaffected side from the affected side. Quantitative asymmetry indices (QAI) were defined as the radiopharmaceutical uptake ratios of the affected side to the unaffected side. Patients were divided into 3 groups by qualitative lymphoscintigraphic patterns: normal, decreased function, and obstruction. Results The MCD was highest in the qualitative obstruction (2.76±2.48) pattern with significant differences from the normal (0.69±0.78) and decreased function (1.65±1.17) patterns. The QAIs of the axillary LNs showed significant differences among the normal (0.82±0.29), decreased function (0.42±0.41), and obstruction (0.18±0.16) patterns. As the QAI of the axillary LN increased, the MCD decreased. The QAIs of the upper limbs were significantly higher in the obstruction (3.12±3.07) pattern compared with the normal (1.15±0.10) and decreased function (0.79±0.30) patterns. Conclusion Quantitative lymphoscintigraphic analysis is well correlated with both commonly used qualitative lymphoscintigraphic analysis and circumference differences in the upper limbs of patients with breast cancer surgery with ALND. Quantitative lymphoscintigraphy may be a good alternative assessment tool for diagnosing lymphedema after breast cancer surgery with ALND.
Abstract
Objective To evaluate the validity of quantitative lymphoscintigraphy as a useful lymphedema assessment tool for patients with breast cancer surgery including axillary lymph node dissection (ALND). Methods We recruited 72 patients with lymphedema after breast cancer surgery that included ALND. Circumferences in their upper limbs were measured in five areas: 15 cm proximal to the lateral epicondyle (LE), the elbow, 10 cm distal to the LE, the wrist, and the metacarpophalangeal joint. Then, maximal circumference difference (MCD) was calculated by subtracting the unaffected side from the affected side. Quantitative asymmetry indices (QAI) were defined as the radiopharmaceutical uptake ratios of the affected side to the unaffected side. Patients were divided into 3 groups by qualitative lymphoscintigraphic patterns: normal, decreased function, and obstruction. Results The MCD was highest in the qualitative obstruction (2.76±2.48) pattern with significant differences from the normal (0.69±0.78) and decreased function (1.65±1.17) patterns. The QAIs of the axillary LNs showed significant differences among the normal (0.82±0.29), decreased function (0.42±0.41), and obstruction (0.18±0.16) patterns. As the QAI of the axillary LN increased, the MCD decreased. The QAIs of the upper limbs were significantly higher in the obstruction (3.12±3.07) pattern compared with the normal (1.15±0.10) and decreased function (0.79±0.30) patterns. Conclusion Quantitative lymphoscintigraphic analysis is well correlated with both commonly used qualitative lymphoscintigraphic analysis and circumference differences in the upper limbs of patients with breast cancer surgery with ALND. Quantitative lymphoscintigraphy may be a good alternative assessment tool for diagnosing lymphedema after breast cancer surgery with ALND.
참고문헌 (34)
- Deo SV, "Prevalence and risk factors for development of lymphedema following breast cancer treatment", Indian J Cancer, 41, pp.8~12 (2004)
- Warren AG, "Lymphedema:a comprehensive review", Ann Plast Surg, 59, pp.464~472 (2007)
- McLaughlin SA, "Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: objective measurements", J Clin Oncol, 26, pp.5213~5219 (2008)
- Tiwari A, "Differential diagnosis, investigation, and current treatment of lower limb lymphedema", Arch Surg, 138, pp.152~161 (2003)
- Bar Ad V, "Time course of mild arm lymphedema after breast conservation treatment for early-stage breast cancer", Int J Radiat Oncol Biol Phys, 76, pp.85~90 (2010)
- 황정민, "Long-Term Effects of Complex Decongestive Therapy in Breast Cancer Patients With Arm Lymphedema After Axillary Dissection", Annals of Rehabilitation Medicine, 37(5), pp.690~697 (2013), 대한재활의학회
- Johansson K, "Breast cancer patients’ experiences of lymphoedema", Scand J Caring Sci, 17, pp.35~42 (2003)
- Rietman JS, "Treatment-related upper limb morbidity 1 year after sentinel lymph node biopsy or axillary lymph node dissection for stage I or II breast cancer", Ann Surg Oncol, 11, pp.1018~1024 (2004)
- Norman SA, "Lymphedema in breast cancer survivors: incidence, degree, time course, treatment, and symptoms", J Clin Oncol, 27, pp.390~397 (2009)
- Deltombe T, "Reliability and limits of agreement of circumferential, water displacement, and optoelectronic volumetry in the measurement of upper limb lymphedema", Lymphology, 40, pp.26~34 (2007)
- Szuba A, "The third circulation: radionuclide lymphoscintigraphy in the evaluation of lymphedema", J Nucl Med, 44, pp.43~57 (2003)
- Yuan Z, "The role of radionuclide lymphoscintigraphy in extremity lymphedema", Ann Nucl Med, 20, pp.341~344 (2006)
- Sadeghi R, "Diagnostic application of lymphoscintigraphy in the management of lymphoedema", Hell J Nucl Med, 13, pp.6~10 (2010)
- International Society of Lymphology, "The diagnosis and treatment of peripheral lymphedema: Consensus document of the International Society of Lymphology", Lymphology, 36, pp.84~91 (2003)
- Dalia RM, "Qualitative and quantitative lymphoscintigraphy in the evaluation of lower limbs lymphedema", Braz Arch Biol Technol, 48, pp.159~162 (2005)
- Hwang JH, "Lymphscintigraphy predicts response to complex physical therapy in patients with early stage extremity lymphedema", Lymphology, 40, pp.172~176 (2007)
- Yoo J, "Prognostic value of lymphoscintigraphy in patients with gynecological cancer-related lymphedema", J Surg Oncol, 109, pp.760~763 (2014)
- Stanton AW, "A quantitative lymphoscintigraphic evaluation of lymphatic function in the swollen hands of women with lymphoedema following breast cancer treatment", Clin Sci (Lond), 110, pp.553~561 (2006)
- Pecking AP, "Relationship between lymphoscintigraphy and clinical findings in lower limb lymphedema (LO): toward a comprehensive staging", Lymphology, 41, pp.1~10 (2008)
- Francois A, "Does medical treatment of lymphedema act by increasing lymph flow?", Vasa, 18, pp.281~286 (1989)
- Franco A, "La lymphoscintigraphie indirecte: son intérêt pour le diagnostic étiologique des oedèmes des membres inférieurs de cause non générale", J Biophys Med Nucl, 4, pp.299~303 (1980)
- Szuba A, "Quantitative radionuclide lymphoscintigraphy predicts outcome of manual lymphatic therapy in breast cancerrelated lymphedema of the upper extremity", Nucl Med Commun, 23, pp.1171~1175 (2002)
- Kiel KD, "Early-stage breast cancer:arm edema after wide excision and breast irradiation", Radiology, 198, pp.279~283 (1996)
- Keramopoulos A, "Arm morbidity following treatment of breast cancer with total axillary dissection: a multivariated approach", Oncology, 50, pp.445~449 (1993)
- Piller N, "The diagnosis and treatment of peripheral lymphedema", Lymphology, 42, pp.146~147 (2009)
- Shaitelman SF, "Recent progress in the treatment and prevention of cancer-related lymphedema", CA Cancer J Clin, 65, pp.55~81 (2015)
- Cheville AL, "The grading of lymphedema in oncology clinical trials", Semin Radiat Oncol, 13, pp.214~225 (2003)
- Armer JM., "The problem of post-breast cancer lymphedema:impact and measurement issues", Cancer Invest, 23, pp.76~83 (2005)
- Gebruers N, "Volumetric evaluation of upper extremities in 250healthy persons", Clin Physiol Funct Imaging, 27, pp.17~22 (2007)
- Smoot BJ, "Comparison of diagnostic accuracy of clinical measures of breast cancerrelated lymphedema: area under the curve", Arch Phys Med Rehabil, 92, pp.603~610 (2011)
- Pain SJ, "Side-to-side symmetry of radioprotein transfer from tissue space to systemic vasculature following subcutaneous injection in normal subjects and patients with breast cancer", Eur J Nucl Med Mol Imaging, 30, pp.657~661 (2003)
- Bar Ad V, "Time-course of arm lymphedema and potential risk factors for progression of lymphedema after breast conservation treatment for early stage breast cancer", Breast J, 18, pp.219~225 (2012)
- Ramos SM, "Edema volume, not timing, is the key to success in lymphedema treatment", Am J Surg, 178, pp.311~315 (1999)
- Forner-Cordero I, "Predictive factors of response to decongestive therapy in patients with breast-cancerrelated lymphedema", Ann Surg Oncol, 17, pp.744~751 (2010)
